Comparison of 24-hour ambulatory blood pressure data in hypertensive patients switched from nifedipine-GITS to nifedipine-CC

Pharmacotherapy

Volumn 19, Issue 1 I, 1999, Pages 94-100

  Wurdeman, Richard L ^a   Mooss, Aryan N ^a   Mohiuddin, Syed M ^a   Lucas Jr , B Daniel ^a   Ryschon, Kay L ^a   Hilleman, Daniel E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NIFEDIPINE; NIFEDIPINE COAT CORE; NIFEDIPINE DERIVATIVE; NIFEDIPINE GASTROINTESTINAL THERAPEUTIC SYSTEM; NITRATE; UNCLASSIFIED DRUG;

ADULT; AMBULATORY MONITORING; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG FORMULATION; DRUG INDUCED DISEASE; EDEMA; FEMALE; HEADACHE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; TREATMENT OUTCOME;

ADULT; AGED; BLOOD PRESSURE MONITORING, AMBULATORY; CALCIUM CHANNEL BLOCKERS; DOSAGE FORMS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NIFEDIPINE; PROSPECTIVE STUDIES;

EID: 0032952306     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.19.1.94.30512     Document Type: Article

References (19)

1. MacCarthy EP, Pettis PP, Gibson L. The efficacy and safety of once-daily nifedipine coat-core in the treatment of mild to moderate hypertension. Clin Ther 1993;15(6):963-75.
2. MacCarthy EP, Pettis PP, Gibson L, et al. The safety and efficacy of once-daily nifedipine coat-core in combination with atenolol in hypertensive patients. Clin Ther 1993;15(6):976-87.
3. Frishman WH., Garofalo JL, Rothschild A. The nifedipine gastrointestinal therapeutic system in the treatment of hypertension. Am J Cardiol 1989;64:65F-9.
4. Chung M, Reitberg DP, Gaffney M, et al. Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system: a controlled-release formulation of nifedipine. Am J Med 1987;83(suppl 6B):10-14.
5. Miles Inc. Adalat CC product monograph. West Haven, CT;1993
6. Glasser SP, Jain A, Allenby KS. The efficacy and safety of once-daily nifedipine: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild to moderate diastolic hypertension. Clin Ther 1995;17(1):12-29.
7. Granberry MC, Gardner SF, Schneider EF, et al. Comparison of two formulations of nifedipine during 24-hour ambulatory blood pressure monitoring. Pharmacotherapy 1996;16(5):932-6.
8. Lucas BD Jr, Hilleman DE, Stoysich AM, et al. An open-label study examining the effects of switching patients with stage I-II hypertension controlled on nifedipine gastrointestinal therapeutic system (GITS) to nifedipine coat-core (CC) [abstr]. Pharmacotherapy 1995;15(3):364.
9. Witt DM, Beall DG, Trent D. A calcium channel antagonist target drug program in a group model health maintenance organization [abstr]. Pharmacotherapy 1995;15(3):401.
10. White WB, Dey HM, Schulman P. Assessment of the daily blood pressure load as a determinant of cardiac function in patients with mild-to-moderate hypertension. Am Heart J 1989;118:782-95.
11. O'Brien E, Sheridan J, O'Malley K. Dippers and non-dippers. Lancet 1988;2:397.
12. Verdecchia P, Schillaci G, Porcellati C. Dippers versus non-dippers. J Hypertens 1991;9(suppl 8):S42-4.
13. Shimada K, Kawamoto A, Matsubayashi K, et al. Silent cerebrovascular disease in the elderly: correlation with ambulatory blood pressure. Hypertension 1990;16:692-9.
14. Verdecchia P, Schillaci G, Guerrieri M, et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990;81:528-36.
15. Verdecchia P, Porcellata C, Schillaci G, et al. Ambulatory blood pressure; an independent predictor of prognosis on essential hypertension. Hypertension 1994;24:793-801.
16. O'Brien E, O'Malley K, Cox J, et al. Ambulatory blood pressure monitoring in the evaluation of drug efficacy. Am Heart J 1991;121:999-1006.
17. Anonymous. Approved drug products and legal requirements. In: United States USP dispensing information, 18th ed, vol 3. Rockville, MD: US Pharmacopeial Convention, 1998:212.
18. Hilleman DE, Mohiuddin SM, Lucas BD, et al. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension. Clin Ther 1993;15(6):1002-10.
19. Defina LF, Bookstaver DA, Goldfinger MP, et al. Nifedipine gastrointestinal therapeutic system versus nifedipine coat-core: comparison of efficacy via 24-hour ambulatory blood pressure monitoring. Ann Pharmacother 1997;31:819-22.